ACS Clinical Research Program rss

Treating metastatic prostate cancer now and in the future(Comments Off)

September 1, 2014

The past decade has seen a paradigm shift in the treatment of men with advanced prostate cancer, according to the authors of this month column, a result of improved understanding of disease biology, investment in basic research and identification of rational therapeutic targets, collaboration with industry, and design and completion of well-designed clinical trials.

alliance logo CMYK

NCDB and ACS-CRP: Working together to develop risk-stratified strategies for surveillance

The Patient-Centered Outcomes Research Institute has awarded three research funding contracts to the ACS Cancer Research Program of the Alliance for Clinical Trials in Oncology with the goal of developing a more patient-centered and individualized approach to post-treatment surveillance of colorectal, breast, and lung cancers.

Dr. Morton

SLN surgery for clinically node-positive breast cancer patients treated with neoadjuvant therapy

The ACS Oncology Group Z1071 trial and sentinel lymph node surgery in clinically node-positive patients receiving neoadjuvant chemotherapy are examined in this month’s column.

Neoadjuvant cancer therapy: Benefitting patients and improving cancer care

The rationale for neoadjuvant therapy is explored in this month’s column along with a summary of Alliance clinical trials involving this treatment.

PubMed citations for "quality of life" by year, 1993–2013

Patient quality of life: Vitally important

Surgical quality of life questions can be an important part of assessing the impact of changes in treatment and, therefore, can play a significant role in prospective clinical trials.

More in this category

« Older Posts   


Bulletin of the American College of Surgeons
633 N. Saint Clair St.
Chicago, IL 60611